Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: Comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor

Elihu Estey, Peter Thall, Michael Andreeff, Miloslav Beran, Hagop Kantarjian, Susan O'Brien, Susan Escudier, L. E. Robertson, Charles Koller, Steven Kornblau, Sherry Pierce, Emil J. Freireich, Albert Deisseroth, Michael Keating

Research output: Contribution to journal › Review article › peer-review

307 Scopus citations

Fingerprint

Dive into the research topics of 'Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: Comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor'. Together they form a unique fingerprint.

Medicine & Life Sciences